Clinical studies

Phase I to Phase III studies

Whether you require a full-service solution or standalone services, SCRO has the know-how to support you during all phases of clinical studies, ensuring that your study delivers high-quality results and follows regulatory guidelines, budget, and timelines.

Market approval of a drug or biologic requires a carefully planned clinical development strategy, as well as high-quality efficacy and safety data investigating the right indication, study population, and endpoints during your Phase I to Phase III clinical studies. From first-in-human studies to pivotal trials, SCRO has proven expertise with designing and conducting Phase I to Phase III clinical studies in a wide range of therapeutic areas.

Our clinical study teams have experience working with a variety of IMPs and indications, and the team includes key functions such as project management, clinical operations, monitoring, medical writing, data management, biostatistics, and safety. At SCRO, clinical development is both our expertise and passion, and we would love to partner with you to understand your specific needs and provide custom solutions that fit your journey.

Supporting your clinical studies

Proven expertise

SCRO services for Phase I to Phase III clinical studies:

Clinical studies after market approval

Post-marketing studies

Is your product already approved for market and you need to continue monitoring the safety and efficacy of your drug or biologic in post-marketing studies? Let SCRO help you design and carry out your post-marketing study to achieve a better understanding of your product’s benefit-risk profile.

 

Learn more

Phase I to IV clinical studies

Science that cares
since 2007

We look forward to hearing from you to discuss how we can add value to your clinical studies with custom, fit-for-purpose solutions.